Jerome Benedict Durso - 24 Feb 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Gregory Weaver, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
4
Filing time
25 Feb 2025, 17:46:09 UTC
Previous filing
13 Nov 2023
Next filing
29 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Award $0 +69,800 $0.000000 69,800 24 Feb 2025 Common Stock, par value $0.0001 69,800 $6.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following February 24, 2025 subject to the reporting person's continued service through the applicable vesting date.